Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Asian Pac J Cancer Prev ; 25(6): 2113-2121, 2024 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-38918674

RESUMO

OBJECTIVE: The lack of indicators to measure tumor's invasive biological behavior is an important issue. The aim of this study was to examine the effect of miRNAs 129 and 145 on tumor progression as well as patient survival. METHOD: Seventy five breast cancer (BC) patients and 75 controls were included in this research. Two miRNA expressions were estimated using real-time PCR. Biomarkers for BC detection was tested using ROC curves and AUC. RESULT: miR-129 and miR-145 expressions were significant. miR-129 and miR-145 classifiers (AUC = 0.943 and 0.748, respectively) help diagnose BC. Unlike miR-145, miR-129 did not affect the Kaplan-Meier survival curve analysis for progression-free survival at the end of the trial. The development of transitional cell carcinoma disease was found to have a strong correlation with miR-145 in both univariate and multivariate Cox regression analyses. Additionally, infiltrating + invasive urothelial carcinoma was also found to be correlated with miR-145. Conversely, elevated miR-129 expression in BC patients did not lead to an increase in cancer-specific recurrence or mortality, as observed in both univariate and multivariate Cox regression studies. CONCLUSION: The miRNA signature can help detect survival-associated miRNAs and develop BC miRNA therapeutics.


Assuntos
Biomarcadores Tumorais , MicroRNAs , Recidiva Local de Neoplasia , Neoplasias da Bexiga Urinária , Humanos , MicroRNAs/genética , Neoplasias da Bexiga Urinária/genética , Neoplasias da Bexiga Urinária/patologia , Neoplasias da Bexiga Urinária/mortalidade , Feminino , Biomarcadores Tumorais/genética , Recidiva Local de Neoplasia/genética , Recidiva Local de Neoplasia/patologia , Estudos de Casos e Controles , Pessoa de Meia-Idade , Prognóstico , Taxa de Sobrevida , Idoso , Seguimentos , Carcinoma de Células de Transição/genética , Carcinoma de Células de Transição/patologia , Carcinoma de Células de Transição/mortalidade , Masculino , Curva ROC
2.
Travel Med Infect Dis ; 56: 102636, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37633474

RESUMO

Monkeypox (Mpox) is a transmissible infection induced by the Monkeypox virus (a double-stranded DNA virus), recognised under the family orthopoxvirus genus. Monkeypox, like endemic diseases, is a substantial concern worldwide; thus, comprehending the pathogenesis and mutagenesis of amino acids is indispensable to combat the infection. According to the World Health Organization's report, about 89 thousand cases with 160 mortalities have been reported from 114 countries worldwide. The conventional orthopoxvirus vaccines developed on live attenuated viruses exempted any clinical validation from combating monkeypox due to inadequate immunogenicity, toxicity, instability, and multiple doses. Therefore, novel drug delivery systems come into the conception with high biological and mechanical characteristics to address the resurgence of Global Monkeypox. The edges of metallic biomaterials, novel molecules, and vaccine development in targeted therapy increase the modulation of the immune response and blockage of host-virus interaction, with enhanced stability for the antigens. Thus, this review strives to comprehend the viral cell pathogenesis concerning amino acid mutagenesis and current epidemiological standards of the Monkeypox disease across the globe. Furthermore, the review also recapitulates the various clinical challenges, current therapies, and progressive nanomedicine utilisation in the Monkeypox outbreak reinforced by various clinical trial reports. The contemporary challenges of novel drug delivery systems in Monkeypox treatment cannot be overlooked, and thus, authors have outlined the future strategies to develop successful nanomedicine to combat monkeypox. Future pandemics are inevitable but can be satisfactorily handled if we comprehend the crises, innovate, and develop cutting-edge technologies, especially by delving into frontiers like nanotechnology.


Assuntos
Mpox , Orthopoxvirus , Humanos , Mpox/tratamento farmacológico , Mpox/epidemiologia , Surtos de Doenças , Sistemas de Liberação de Medicamentos , Doenças Endêmicas , Monkeypox virus/genética
3.
Phytother Res ; 37(2): 388-398, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-36580575

RESUMO

In the current study, we aimed to investigate the effect of saffron supplementation on glycemic status, lipid profile, atherogenic indices, and oxidative status in patients with type-2 diabetes (T2DM). In a randomized, double-blind controlled trial, 70 patients were randomly allocated into two groups (n = 35, each) and received 100 mg/day of saffron or placebo for eight weeks. Dietary intake, weight, body mass index (BMI), waist and hip circumferences (WC and HC), waist to hip ratio (WHR), fasting blood sugar (FBS), hemoglobin A1c (HbA1c), insulin, and Homeostatic model assessment for insulin resistance (HOMA-IR), lipid profile, atherogenic indices, oxidative status, and liver enzymes were determined before and after the intervention. At the end of the eighth week, saffron intervention could significantly reduce FBS (7.57%), lipid profile (except high-density lipoprotein cholesterol [HDL-C]), atherogenic indices, and liver enzymes (p < .05). Moreover, saffron could improve oxidative status (nitric oxide [NO] and malondialdehyde [MDA] reduced by 26.29% and 16.35%, respectively). Catalase (CAT) concentration remained unchanged. Saffron supplementation may alleviate T2DM by improving glycemic status, lipid profile, liver enzymes, and oxidative status. Further investigation is necessary to assess possible side effects and confirm the positive effect of saffron as a complementary therapy in clinical recommendations for T2DM.


Assuntos
Crocus , Diabetes Mellitus Tipo 2 , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Hemoglobinas Glicadas , Lipídeos , Método Duplo-Cego , Glicemia
4.
Crit Rev Anal Chem ; : 1-20, 2022 Jun 24.
Artigo em Inglês | MEDLINE | ID: mdl-35749278

RESUMO

Fabricating novel biosensing constructs with high sensitivity and selectivity is highly demanded in food contaminants detection. In this prospect, various nanostructured materials were envisaged to build (bio)sensors with superior sensitivity and selectivity. The desirable biocompatibility, brilliant mechanical strength, ease of surface functionalization, as well as tunable optical and electronic features, portray 2D MXenes as versatile scaffolds for biosensing. In this review, we overviewed the state-of-the-art MXenes-based optical biosensing devices to detect mycotoxins, pesticide residues, antibiotic residues, and food borne-pathogens from foodstuff and environmental matrices. Firstly, the synthesis methods and surface functionalization/modification of MXenes are discussed. Secondly, according to the target analytes, we categorized and presented a detailed account of the newest research progress of MXenes-based optical probes for food contaminants monitoring. The efficiency of all the surveyed probes was assessed on the basis of important factors like response time, detection limit (DL), and sensing range. Lastly, the necessity and requirements for future advances in this emerging MXenes material are also given, followed by challenges and opportunities. We hope that this study will bridge the gap between nanotechnology and food science, offering insights for engineers or scientists in both areas to accelerate the progress of MXenes-based materials for food safety detection.

5.
Int Immunopharmacol ; 97: 107681, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33932697

RESUMO

Cancer is a leading cause of death worldwide and imposes a substantial financial burden. Therefore, it is essential to develop cost-effective approaches to inhibit tumor growth and development. The imbalance of cytokines and chemokines play an important role among different mechanisms involved in cancer development. One of the strongly conserved chemokines that is constitutively expressed in skin epithelia is the chemokine CXCL14. As a member of the CXC subfamily of chemokines, CXCL14 is responsible for the infiltration of immune cells, maturation of dendritic cells, upregulation of major histocompatibility complex (MHC)-I expression, and cell mobilization. Moreover, dysregulation of CXCL14 in several cancers has been identified by several studies. Depending on the type or origin of the tumor and components of the tumor microenvironment, CXCL14 plays a conflicting role in cancer. Although fibroblast-derived CXCL14 has a tumor-supportive role, epithelial-derived CXCL14 mainly inhibits tumor progression. Hence, this review will elucidate what is known on the mechanisms of CXCL14 and its therapeutic approaches in tumor treatment. CXCL14 is a promising approach for cancer immunotherapy.


Assuntos
Antineoplásicos/farmacologia , Biomarcadores Tumorais/metabolismo , Quimiocinas CXC/metabolismo , Neoplasias/imunologia , Antineoplásicos/uso terapêutico , Biomarcadores Tumorais/agonistas , Biomarcadores Tumorais/análise , Biomarcadores Tumorais/antagonistas & inibidores , Quimiocinas CXC/agonistas , Quimiocinas CXC/análise , Quimiocinas CXC/antagonistas & inibidores , Células Dendríticas/efeitos dos fármacos , Células Dendríticas/imunologia , Células Dendríticas/metabolismo , Fibroblastos/efeitos dos fármacos , Fibroblastos/imunologia , Fibroblastos/metabolismo , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/imunologia , Humanos , Neoplasias/diagnóstico , Neoplasias/tratamento farmacológico , Neoplasias/genética , Microambiente Tumoral/efeitos dos fármacos , Microambiente Tumoral/genética , Microambiente Tumoral/imunologia , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA